ORBIT Bleeding Risk Score
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low0–2
- Medium3–3
- High4–7
The ORBIT Bleeding Risk Score calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age ge 75. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
ORBIT bleeding risk score for atrial fibrillation (O'Brien 2015): Older age ≥75 (1), Reduced hemoglobin/anemia (2), Bleeding history (2), Insufficient kidney function eGFR <60 (1), Treatment with antiplatelet (1); total 0-7. 0-2 low, 3 medium, ≥4 high bleeding risk.
Clinical Indication
The ORBIT Bleeding Risk Score is indicated for bedside clinical practice to support ORBIT bleeding risk score for atrial fibrillation (O'Brien 2015): Older age ≥75 (1), Reduced hemoglobin/anemia (2), Bleeding history (2), Insufficient kidney function eGFR <60 (1), Treatment with antiplatelet (1); total 0-7. 0-2 low, 3 medium, ≥4 high bleeding risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.
ORBIT = age≥75(1) + anemia(2) + bleeding history(2) + eGFR<60(1) + antiplatelet(1).
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age_ge_75 | string | Yes | Age 75 or older |
| anemia | string | Yes | Reduced hemoglobin / anemia |
| bleeding_history | string | Yes | History of bleeding |
| ckd | string | Yes | eGFR <60 mL/min/1.73m² |
| antiplatelet | string | Yes | Concomitant antiplatelet treatment |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2 | Low | Low bleeding risk |
| 3–3 | Medium | Medium bleeding risk |
| 4–7 | High | High bleeding risk |
Evidence-Based References (EBM)
- O'Brien EC, Simon DN, Thomas LE, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015;36(46):3258-3264.